An organic electroluminescence device including: a cathode; an anode; and at least one emitting layer disposed between the cathode and the anode, wherein the emitting layer contains a first host material, a second host material, and a dopant material, wherein the first host material is a compound represented by the following formula (1), the second host material is a compound represented by the following formula (2), and the first host material and the second host material are different compounds.

##STR00001##

The present invention relates to bisbenzofuran-fused 2,8-diaminoindeno[1,2-b]fluorene derivatives and related compounds of formula (1) as materials for organic electroluminescent devices (OLEDs).

Methods of synthesizing substituted tetracycline compounds are provided.

An organic compound that emits red light having a long wavelength and that is represented by formula [1] below. In the formula [1], R.sub.1 to R.sub.24 are each independently selected from a hydrogen atom or a substituent. ##STR00001##

The present disclosure relates to display technologies, and particularly discloses an organic electroluminescent device. This organic electroluminescent device includes a light-emitting layer, the light-emitting includes an exciplex composed of a donor molecule and an acceptor molecule, and a wide band gap material for increasing the inter-molecular spacing between the donor molecule and the acceptor molecule. According to the device of the present disclosure, the degree of orbital overlap of HOMO and LUMO of the formed exciplex and the singlet-triplet energy level difference can be reduced, the reverse intersystem crossing rate (k.sub.RISC) of the exciplex host can be increased, the Föster energy transferred to the guest molecule can be enhanced, and the efficiency and the lifetime of the device can be improved.

Therapeutic compositions comprising one or more agents that inhibit CXXC5-DVL interface, and methods of administering those therapeutic compositions to model, treat, reduce resistance to treatment, prevent, and diagnose a condition/disease associated with growth or a related clinical condition thereof, are disclosed.

The present invention discloses a 5,12-dihydrotetracene derivative and an organic electroluminescence device employing the 5,12-dihydrotetracene derivative as the thermally activated delayed fluorescence host material or the thermally activated delayed fluorescence dopant material in the light emitting layer. The organic electroluminescence device of the present invention exhibits improved performance, such as reduced power consumption and increased current efficiency.

An organic compound that emits red light having a long wavelength and that is represented by formula [1] below. In the formula [1], R.sub.1 to R.sub.24 are each independently selected from a hydrogen atom or a substituent.

##STR00001##

The present invention relates to a process for preparing a partially hydrogenated polyacene, and a novel intermediate used in such process; also the present invention relates to a process for preparing the corresponding conjugated polyacenes.

The present disclosure relates to display technologies, and particularly discloses an organic electroluminescent device. This organic electroluminescent device includes a light-emitting layer, the light-emitting includes an exciplex composed of a donor molecule and an acceptor molecule, and a wide band gap material for increasing the inter-molecular spacing between the donor molecule and the acceptor molecule. According to the device of the present disclosure, the degree of orbital overlap of HOMO and LUMO of the formed exciplex and the singlet-triplet energy level difference can be reduced, the reverse intersystem crossing rate (K.sub.RISC) of the exciplex host can be increased, the Fster energy transferred to the guest molecule can be enhanced, and the efficiency and the lifetime of the device can be improved.